Primary Menu
Skip to content
About
Mission & Values
In The Community
Management
Board of Directors
Contact
R&D
Antisense Technology
Discovery Platform
Basic Science
Antisense Drugs
Medicinal Chemistry
Antisense Approaches
Intellectual Property
Strategic Alliances
Pharmaceutical Partners
Satellite Companies
Pipeline
Patients
Patient Resources
Clinical Trials
Drug Approval Process
Medical Professionals
ATTR Expanded Access Program
Investors & Media
News & Events
Press Releases
Archived Webcasts
Event Calendar
Corporate Governance
Board of Directors
Board Criteria
Director Compensation and Board Meeting Attendance
Committee Composition
Certificates of Incorporation
Bylaws
Code of Ethics
Clawback Policy
RSU Holding Guidelines
Annual Meeting
Stock Information
Stock Quote
Stock Chart
Analyst Coverage
Ownership Profile
Financials
Annual Reports
SEC Filings
Shareholder Services
Investor FAQ
Information Request
Press Kit
Careers
Available Positions
Search Open Jobs
Browse Open Jobs
Edit Your Profile
View Submitted Applications
Culture & Core Principles
Benefits
Equal Opportunity
Intern Program
Post-Doctoral Program
Spotlight

                            Dr. C. Frank Bennett Receives Prestigious Breakthrough Prize in Life Sciences in Recognition of the Transformational Drug SPINRAZA® and Ionis’ Antisense Technology                        
More »
News
November 12, 2018
Phase 2 Results on AKCEA-APO(a)-LRx Presented in Late-Breaking Clinical Trial Presentation at AHA Scientific Sessions
More »
November 9, 2018
Ionis Pharmaceuticals to Host Investor Day
More »
November 8, 2018
Akcea and Ionis Announce Late-Breaking Presentation of Data From AKCEA-APO(a)-LRx at the American Heart Association Scientific Sessions
More »
November 7, 2018
Ionis Pharmaceuticals to Present at Upcoming Investor Conferences
More »
Events

                                                11-10-2018 - 11-12-2018                                                

                                                AHA Scientific Sessions 2018                                            

                                                11-14-2018                                                

                                                Stifel 2018 Healthcare Conference                                            

                                                11-28-2018                                                

                                                30th Annual Piper Jaffray Healthcare Conference                                             
Latest Updates
Ionis Pharmaceuticals to Host Investor Day https://t.co/QeMxz0Cvlu via @ionispharma
#ICYMI Our own Dr. C. Frank Bennett won the 2019 #BreakthroughPrize in Life Sciences recognizing his work on the transformational drug SPINRAZA® for #SMA 
Follow us
Clinical Trials
We have numerous ongoing clinical trials designed to evaluate our drugs in a variety of health conditions. 
More »
Home
Contact
Terms of Use and Forward-Looking Statements
Privacy Policy
About
Mission & Values
In The Community
Management
Board of Directors
Contact
R&D
Antisense Technology
Discovery Platform
Basic Science
Antisense Drugs
Medicinal Chemistry
Antisense Approaches
Intellectual Property
Strategic Alliances
Pharmaceutical Partners
Satellite Companies
Pipeline
Patients
Patient Resources
Clinical Trials
Drug Approval Process
Medical Professionals
ATTR Expanded Access Program
Investors & Media
News & Events
Press Releases
Archived Webcasts
Event Calendar
Corporate Governance
Board of Directors
Board Criteria
Director Compensation and Board Meeting Attendance
Committee Composition
Certificates of Incorporation
Bylaws
Code of Ethics
Clawback Policy
RSU Holding Guidelines
Annual Meeting
Stock Information
Stock Quote
Stock Chart
Analyst Coverage
Ownership Profile
Financials
Annual Reports
SEC Filings
Shareholder Services
Investor FAQ
Information Request
Press Kit
Careers
Available Positions
Search Open Jobs
Browse Open Jobs
Edit Your Profile
View Submitted Applications
Culture & Core Principles
Benefits
Equal Opportunity
Intern Program
Post-Doctoral Program